Surgeons and researchers have welcomed an advancement in tracheal surgery that provides a life-changing solution for children with Mucopolysaccharidosis IVA (Morquio A syndrome).
In a pioneering collaboration, clinicians at the UK’s Royal Manchester Children’s Hospital (RMCH), part of Manchester University NHS Foundation Trust (MFT), and Great Ormond Street Hospital (GOSH) have developed and implemented a novel surgical technique to address critical airway obstructions caused by the rare genetic condition.
In the largest study of its kind globally, the innovative procedure was successfully performed on 11 patients aged 11 to 19, both from the UK and internationally.
These individuals suffered from severe airway obstructions linked to Morquio A syndrome, which affects approximately three children in England each year and is currently diagnosed in 90 patients across the UK.
Historically, tracheal resection surgery for Morquio A patients was considered high-risk, requiring complex operations involving the aorta and cardiopulmonary bypass (CPB).
However, the new technique, spearheaded by Professor Iain A Bruce and Mr Richard Hewitt (GOSH), eliminates the need for CPB by removing sections of the windpipe and part of the breastbone through a neck incision. This alleviates airway blockages in a safer and less invasive manner.
Professor Bruce, who has treated Morquio A patients for years, said: ‘his collaborative research is a real game-changer. For the first time, we have a safe and effective way to address life-limiting narrowing of the windpipe in this remarkable group of individuals.
‘This study represents a significant step forward in offering a promising, new solution for our patients with this devastating condition, and we are hopeful it will provide a life-changing and safer alternative, improving their quality of life.
‘The next challenge is to better understand when surgery to shorten the kinking of the windpipe should be considered. This collaboration within the NHS provides the blueprint for further work to improve the quality of life for people with rare diseases.’
The procedure leverages Advanced Airway Analytics, including 3D tracheal modelling and virtual endoscopy, enhancing visualisation and surgical precision.
The surgery represents the culmination of a multidisciplinary effort involving RMCH, GOSH, and the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital. It also highlights the importance of research participation.
Looking ahead, the researchers emphasise the need for long-term follow-up to confirm the procedure’s enduring benefits.
The study was published in the Orphanet Journal of Rare Diseases.
